Tag: Diabetes
Fair Prospects ahead for Sirona Biochem with Grant of Key Patent...
Sirona Biochem (OTCPK: SRBCF), a biopharmaceutical company focused on discovering novel cosmetic and pharmaceutical compounds, announced the grant of a patent for TFC-1067, its...
Obalon Granted First US Patent for its Proprietary Intragastric Balloon System.
Obalon Therapeutics (NASDAQ: OBLN), the manufacturer of the first and only FDA-approved swallowable, gas-filled intragastric balloon system to combat obesity, has announced the grant...
Emerging Treatment Paradigms in Focal Segmental Glomerulosclerosis (FSGS)
Focal segmental glomerulosclerosis (FSGS) is a disease caused by the degeneration of glomeruli, the filtering system of the kidney’s and is caused by factors...
PhaseBio poised to make rapid strides in the Anti-Coagulant Reversal Market
PhaseBio’s (NASDAQ: PHAS), PB2452 is the new drug on the block, which has received a breakthrough therapy status from the FDA in April 2019....
Is Autologous Stem Cell Therapy the next frontier of medicine?
Stem Cell Therapy is emerging as the future of therapeutics for numerous diseases and disorders which have hitherto been unaddressed. The growing awareness of...
New Therapeutics rise to the occasion for the treatment of Erectile Dysfunction
Erectile dysfunction (ED) commonly called impotence is a sexual dysfunction marked by the inability to develop or maintain an erection. ED though not fatal, can severely affect...
Companies In Focus In The Type 2 Diabetes Market
Diabetes is a silent killer which is slowly reaching endemic proportions in developed as well as developing countries. The rise in obesity, sedentary lifestyles,...
We are looking for talented interns to learn and help investors find valuable companies.